Dietary strategies of immunomodulation in infants at risk for celiac disease

Proceedings of the Nutrition Society

Volumn 69, Issue 3, 2010, Pages 347-353

  Nova, Esther ^a   Pozo, Tamara ^a   Sanz, Yolanda ^b   Marcos, Ascensión ^a  

^a INSTITUTO DEL FRÍO CSIC   (Spain)

^b INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Breast feeding; Celiac disease; Disease risk and prevention; Gluten introduction; Probiotics; Tolerance to gluten

Indexed keywords

GLUTEN; LEUKOCYTE ANTIGEN; PEPTIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; PROLYL ENDOPEPTIDASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TOLL LIKE RECEPTOR;

AMINO ACID SUBSTITUTION; ANTIGEN PRESENTATION; AUTOIMMUNITY; BARLEY; BREAST FEEDING; CELIAC DISEASE; CELLULAR IMMUNITY; COHORT ANALYSIS; CONFERENCE PAPER; DIET; DIET THERAPY; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENETIC SUSCEPTIBILITY; HEALTH HAZARD; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFANT; INGESTION; INNATE IMMUNITY; INTESTINE FLORA; LEUKOCYTE; RISK REDUCTION; RYE; SMALL INTESTINE; T LYMPHOCYTE; TISSUE INJURY; VIRUS INFECTION; WHEAT;

AGE FACTORS; BREAST FEEDING; CELIAC DISEASE; DIET; GLUTENS; HUMANS; IMMUNOMODULATION; INFANT;

HORDEUM; SECALE CEREALE; TRITICUM AESTIVUM;

EID: 77957367108     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665110001825     Document Type: Conference Paper

References (58)

1. Gianfrani C, Auricchio S & Troncone R (2005) Adaptive and innate immune responses in celiac disease. Immunol Lett 99, 141-145.
2. Meresse B, Ripoche J, Heyman M et al. (2009) Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. Mucosal Immunol 2, 8-23.
3. Guandalini S & Setty M (2008) Celiac disease. Curr Opin Gastroenterol 24, 707-712.
4. Van Heel DA, Hunt K, Greco L et al. (2005) Genetics in celiac disease. Best Pract Res Clin Gastroenterol 19, 323-339.
5. Molberg O, Mcadam SN, Korner R et al. (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4, 713-717.
6. Van de Wal Y, Kooy Y, van Veelen P et al. (1998) Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 161, 1585-1588.
7. Raki M, Tollefsen S, Molberg Ø et al. (2006) A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology 131, 428-438.
8. de Kauwe AL, Chen Z, Anderson RP et al. (2009) Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. J Immunol 182, 7440-7450.
9. Black KE, Murray JA & David CS (2002) HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol 169, 5595-5600.
10. D'Arienzo R, Maurano F, Luongo D et al. (2008) Adjuvant effect of Lactobacillus casei in a mouse model of gluten sensitivity. Immunol Lett 119, 78-83.
11. Kutlu T, Brousse N, Rambaud C et al. (1993) Numbers of T cell receptor (TCR) alpha beta+ but not of TcR gamma delta + intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet. Gut 34, 208-214.
12. Bhagat G, Naiyer AJ, Shah JG et al. (2008) Small intestinal CD8 + TCRgammadelta + NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J Clin Invest 118, 281-293.
13. Meresse B, Chen Z, Ciszewski C et al. (2004) Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357-366.
14. Hue S, Mention JJ, Monteiro RC et al. (2004) A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21, 367-377.
15. Maiuri L, Ciacci C, Ricciardelli I et al. (2003) Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362, 30-37.
16. Di Sabatino A, Ciccocioppo R, Cupelli F et al. (2006) Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 55, 469-477.
17. Monteleone G, Pender SL, Alstead E et al. (2001) Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 48, 425-429.
18. Stene LC, Honeyman MC, Hoffenberg EJ et al. (2006) Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 101, 2333-2340.
19. Plot L & Amital H (2009) Infectious associations of Celiac disease. Autoimmun Rev 8, 316-319.
20. Zanoni G, Navone R, Lunardi C et al. (2006) In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med 3, e358.
21. Xu D, Liu H & Komai-Koma M (2004) Direct and indirect role of Toll-like receptors in T cell mediated immunity. Cell Mol Immunol 1, 239-246.
22. Szebeni B, Veres G, Dezsofi A et al. (2007) Increased mucosal expression of Toll-like receptor (TLR) 2 and TLR4 in coeliac disease. J Pediatr Gastroenterol Nutr 45, 187-193.
23. Akobeng AK, Ramanan AV, Buchan I et al. (2006) Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child 91, 39-43.
24. Ivarsson A, Hernell O, Stenlund H et al. (2002) Breastfeeding protects against celiac disease. Am J Clin Nutr 75, 914-921.
25. Ivarsson A, Persson LA, Nyström L et al. (2000) Epidemic of coeliac disease in Swedish children. Acta Paediatr 89, 165-171.
26. Myléus A, Ivarsson A, Webb C et al. (2009) Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 49, 170-176.
27. Agostoni C & Shamir R Can a change in policy of complementary infant feeding reduce the risk for type 1 diabetes and celiac disease? Pediatr Endocrinol Rev 6, 2-4.
28. Troncone R, Ivarsson A, Szajewska H et al. (2008) Members of European Multistakeholder Platform on CD (CDEUSSA) (2008) Review article: future research on coeliac disease - a position report from the European multistakeholder platform on coeliac disease (CDEUSSA). Aliment Pharmacol Ther 27, 1030-1043.
29. Norris JM, Barriga K, Hoffenberg EJ et al. (2005) Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 293, 2343-2351.
30. Lammers KM, Lu R, Brownley J et al. (2008) Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 135, 194-204.
31. Agostoni C, Decsi T, Fewtrell M et al. ESPGHAN Committee on Nutrition (2008) Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 46, 99-110.
32. Agostoni C, Braegger C, Decsi T et al. ESPGHAN Committee on Nutrition (2009) Breast-feeding: A Commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 49, 112-125.
33. Mowat AM, Faria AM & Weiner HL (2005) Oral tolerance: basic mechanisms and clinical implications. In Mucosal immunology, 3rd ed., pp. 487-538 [J Mestecky, J Bienenstock and ME Lamm, editors]. San Diego, CA: Academic Press.
34. Macdonald TT & Monteleone G (2005) Immunity, inflammation, and allergy in the gut. Science 307, 1920-1925.
35. Mowat AM, Parker LA, Beacon-Sharp H et al. (2004) Oral tolerance: overview and historical perspectives. Ann NY Acad Sci 1029, 1-8.
36. Cools N, Ponsaerts P, Van Tendeloo VF et al. (2007) Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J Leukoc Biol 82, 1365-1374.
37. Guermonprez P, Valladeau J, Zitvogel L et al. (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20, 621.
38. Strobel S & Mowat AM (2006) Oral tolerance and allergic responses to food proteins. Curr Opin Allergy Clin Immunol 6, 207-213.
39. Lowrey JL, Savage ND, Palliser D et al. (1998) Induction of tolerance via the respiratory mucosa. Int Arch Allergy Immunol 116, 93-102.
40. Senger S, Luongo D, Maurano F et al. (2003) Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice. Immunol Lett 88, 127-134.
41. Fasano A, Araya M, Bhatnagar S et al. (2008) Celiac Disease Working Group, FISPGHAN. Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition consensus report on celiac disease. J Pediatr Gastroenterol Nutr 47, 214-219.
42. De Palma G, Capilla A, Nadal I et al. (2009) Interplay between human leukocyte antigen genes and the microbial colonization process of the newborn intestine. Curr Issues Mol Biol 12, 1-10.
43. Brenner M, Laragione T, Yarlett NC et al. (2007) Genetic regulation of T regulatory, CD4, and CD8 cell numbers by the arthritis severity loci Cia5a, Cia5d, and the MHC/Cia1 in the rat. Mol Med 13, 277-287.
44. Bisikirska B, Colgan J, Luban J et al. (2005) TCR stimulation with modified anti-CD3 mAb expands CD8 + T cell population and induces CD8+CD25+ Tregs. J Clin Invest 115, 2904-2913.
45. Van Heel DA, Franke L, Hunt KA et al. (2007) A genomewide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 39, 827-829.
46. *0201. Alterations in circulating T cell receptor gamma/delta subsets. Arthritis Rheum 39, 1733-1739.
47. Rautava S & Isolauri E (2002) The development of gut immune responses and gut microbiota: effects of probiotics in prevention and treatment of allergic disease. Curr Issues Intest Microbiol 3, 15-22.
48. Nadal I, Donat E, Ribes-Koninckx C et al. (2007) Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol 56 (Pt 12), 1669-1674.
49. Menningen R & Bruewer M (2009) Effect of probiotics on intestinal barrier function. Ann NY Acad Sci 1165, 183-189.
50. Rossi M, Maurano F & Luongo D (2005) Immunomodulatory strategies for celiac disease. Int Rev Immunol 24, 479-499.
51. Gianfrani C, Siciliano RA, Facchiano AM et al. (2007) Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 133, 780-789.
52. Xia J, Bergseng E, Fleckenstein B et al. (2007) Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease. Bioorg Med Chem 15, 6565-6573.
53. Fraser JS, Engel W, Ellis HJ et al. (2003) Coeliac disease: in vivo toxicity of the putative immunodominant epitope. Gut 52, 1698-1702. (Pubitemid 37510388)
54. Branski D, Fasano A & Troncone R (2006) Latest developments in the pathogenesis and treatment of celiac disease. J Pediatr 149, 295-300.
55. Silano M, Vincentini O, Iapello A et al. (2008) Antagonist peptides of the gliadin T cell stimulatory sequences: a therapeutic strategy for celiac disease. J Clin Gastroenterol 42, Suppl 3, Pt 2, S191-S192.
56. Kapoerchan VV, Wiesner M, Overhand M et al. (2008) Design of azidoproline containing gluten peptides to suppress CD4 + T cell responses associated with celiac disease. Bioorg Med Chem 16, 2053-2062.
57. Stepniak D, Spaenij-Dekking L, Mitea C et al. (2006) Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. Am J Physiol Gastrointest Liver Physiol 291, G621-G629.
58. Ehren J, Govindarajan S, Morón B et al. (2008) Protein engineering of improved prolyl endopeptidases for celiac sprue therapy. Protein Eng Des Sel 21, 699-707.